Incidence and prevalence of epilepsy among older U.S. Medicare beneficiaries

E Faught, J Richman, R Martin, E Funkhouser, R Foushee, P Kratt, Y Kim, K Clements, N Cohen, D Adoboe, R Knowlton, M Pisu, E Faught, J Richman, R Martin, E Funkhouser, R Foushee, P Kratt, Y Kim, K Clements, N Cohen, D Adoboe, R Knowlton, M Pisu

Abstract

Objective: To determine the prevalence and incidence of epilepsy among U.S. Medicare beneficiaries aged 65 years old and over, and to compare rates across demographic groups.

Methods: We performed a retrospective analysis of Medicare administrative claims for 2001-2005, defining prevalent cases as persons with ≥1 claim with diagnosis code 345.xx (epilepsy) or 2 or more with diagnosis code 780.3x (convulsion) ≥1 month apart, and incident cases as prevalent cases with 2 years immediately before diagnosis without such claims. Prevalence and incidence rates were calculated for the years 2003-2005 using denominators estimated from a 5% random sample of Medicare beneficiaries. Results were correlated with gender, age, and race.

Results: We identified 282,661 per year on average during 2001-2005 (a total of 704,243 unique cases overall), and 62,182 incident cases per year on average during 2003-2005. Average annual prevalence and incidence rates were 10.8/1,000 and 2.4/1,000. Overall, rates were higher for black beneficiaries (prevalence 18.7/1,000, incidence 4.1/1,000), and lower for Asians (5.5/1,000, 1.6/1,000) and Native Americans (7.7/1,000, 1.1/1,000) than for white beneficiaries (10.2/1,000, 2.3/1,000). Incidence rates were slightly higher for women than for men, and increased with age for all gender and race groups.

Conclusions: Epilepsy is a significant public health problem among Medicare beneficiaries. Efforts are necessary to target groups at higher risk, such as minorities or the very old, and to provide the care necessary to reduce the negative effects of epilepsy on quality of life.

Figures

Figure. Frequency of epilepsy by race, gender,…
Figure. Frequency of epilepsy by race, gender, and age
(A) Average prevalence rates of epilepsy by race and gender groups and by age at first observed seizure for Medicare beneficiaries with a claim-based diagnosis of epilepsy (2003–2005). (B) Average incidence rates of epilepsy by race and gender groups and by age at first observed seizure for Medicare beneficiaries with a claim-based diagnosis of epilepsy (2003–2005). Other race indicates Asian or Native American.

References

    1. Rowan AJ. What we owe our seniors with epilepsy: thoughts on quality of life. Epilepsy Behav 2000; 1: 215– 216
    1. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984. Epilepsia 1993; 34: 453– 468
    1. Holden EW, Thanh Nguyen H, Grossman E, et al. Estimating prevalence, incidence, and disease-related mortality for patients with epilepsy in managed care organizations. Epilepsia 2005; 46: 311– 319
    1. Parko K, Thurman DJ. Prevalence of epilepsy and seizures in the Navajo Nation 1998–2002. Epilepsia 2009; 50: 2180– 2185
    1. Schachter SC, Cramer GW, Thompson GD, Chaponis RJ, Mendelson MA, Lawhorne L. An evaluation of antiepileptic drug therapy in nursing facilities. J Am Geriatr Soc 1998; 46: 1137– 1141
    1. Hauser WA. Seizure disorders: the changes with age. Epilepsia 1992; 33 suppl 4: S6– S14
    1. Hussain SA, Haut SR, Lipton RB, Derby C, Markowitz SY, Shinnar S. Incidence of epilepsy in a racially diverse, community-dwelling, elderly cohort: results from the Einstein aging study. Epilepsy Res 2006; 71: 195– 205
    1. Holden EW, Grossman E, Nguyen HT, et al. Developing a computer algorithm to identify epilepsy cases in managed care organizations. Dis Manag 2005; 8: 1– 14
    1. National Cancer Institute. Surveillance Epidemiology and End Results (SEER) Cancer Statistics Review 1975–2008. Available at: Accessed May 19, 2011
    1. Hauser WA, Annegers JF, Rocca WA. Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin Proc 1996; 71: 576– 586
    1. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the “common” neurologic disorders? Neurology 2007; 68: 326– 337
    1. Forsgren L, Bucht G, Eriksson S, Bergmark L. Incidence and clinical characterization of unprovoked seizures in adults: a prospective population-based study. Epilepsia 1996; 37: 224– 229
    1. Haerer AF, Anderson DW, Schoenberg BS. Prevalence and clinical features of epilepsy in a biracial United States population. Epilepsia 1986; 27: 66– 75
    1. Luhdorf K, Jensen LK, Plesner AM. Epilepsy in the elderly: incidence, social function, and disability. Epilepsia 1986; 27: 135– 141
    1. Hollingsworth J, Alsikafi M, Coombs D. The Prevalence of the Development Disabilities in Alabama: Findings from the Research: Mental Retardation, Cerebral Palsy and Epilepsy in Alabama: A Sociological Analysis. Tuscaloosa: The University of Alabama Press; 1971: 88–110
    1. Annegers JF, Dubinsky S, Coan SP, Newmark ME, Roht L. The incidence of epilepsy and unprovoked seizures in multiethnic, urban health maintenance organizations. Epilepsia 1999; 40: 502– 506
    1. Theodore WH, Spencer SS, Wiebe S, et al. Epilepsy in North America: a report prepared under the auspices of the global campaign against epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization. Epilepsia 2006; 47: 1700– 1722
    1. Ramsay RE, Rowan AJ, Pryor FM. Special considerations in treating the elderly patient with epilepsy. Neurology 2004; 62 5 suppl 2: S24– S29
    1. Faught E. Epidemiology and drug treatment of epilepsy in elderly people. Drugs Aging 1999; 15: 255– 269
    1. Hermann B, Seidenberg M, Sager M, et al. Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsy. Epilepsia 2008; 49: 731– 740
    1. Silverman IE, Restrepo L, Mathews GC. Poststroke seizures. Arch Neurol 2002; 59: 195– 201
    1. Bladin CF, Alexandrov AV, Bellavance A, et al. Seizures after stroke: a prospective multicenter study. Arch Neurol 2000; 57: 1617– 1622
    1. Rowan AJ, Ramsay RE, Collins JF, et al. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005; 64: 1868– 1873
    1. Leppik IE. Treatment of epilepsy in the elderly. Curr Treat Options Neurol 2008; 10: 239– 245

Source: PubMed

3
订阅